Finance

Beta
Lists
SKYE:NASDAQ
Skye Bioscience Inc
$0.71
+4.33%
(+0.029) 1D
$0.71
0.00% (0.00)
Pre-market
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
$0.68
High
$0.73
Low
$0.68
Mkt. cap
24.86M
Avg. vol.
180.98K
Volume
100.00
52-wk high
$5.75
52-wk low
$0.57
EPS
-$1.45
Beta
2.95
Shares outstanding
35.14M
No. of employees
2
Open
$0.68
High
$0.73
Low
$0.68
Mkt. cap
24.86M
Avg. vol.
180.98K
Volume
100.00
52-wk high
$5.75
52-wk low
$0.57
EPS
-$1.45
Beta
2.95
Shares outstanding
35.14M
No. of employees
2
News stories
From sources across the web
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
SectorBiotechnology
Websiteskyebioscience.com
Analyst ratings
Based on 3 analysts giving stock ratings to SKYE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SKYE in the last 3 months.
Highest
Current $0.71
$20.00 (+2,723.26%)
Average
$13.00 (+1,735.12%)
Lowest
$6.00 (+746.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$20.00
+2,723.3%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$6.00
+747%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
$10.00
+1,311.6%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
$2.00
+182.3%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.34M
9.36M
11.47M
7.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.91M
3.91M
3.43M
4.74M
Operating expense
18.24M
13.26M
14.90M
12.67M
Total operating expenses
18.24M
13.26M
14.90M
12.67M
Operating income
-18.24M
-13.26M
-14.90M
-12.67M
Other non operating income
-
-
-502.00
-2.41K
EBT including unusual items
-17.62M
-12.75M
-14.44M
-12.51M
EBT excluding unusual items
-17.71M
-12.85M
-14.62M
-12.51M
Income tax expense
3.40K
-
-
-
Effective tax rate
-0.02%
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.62M
-12.75M
-14.44M
-12.51M
Net profit margin
-
-
-
-
Earnings per share
-0.45
-0.32
-0.37
-0.32
Interest and investment income
533.09K
418.47K
274.10K
169.62K
Interest expense
-
-
-
-2.20K
Net interest expenses
533.09K
418.47K
274.10K
167.42K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.06M
-13.09M
-14.72M
-12.50M
Gain or loss from assets sale
-89.36K
-91.40K
-179.99K
7.62K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of SKYE
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer